Article Type
Changed
Tue, 04/30/2019 - 07:06
Display Headline
Is intensive glycemic control worth the expense?
Article PDF
Author and Disclosure Information

Richard C. Eastman, MD
Director, Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Disease

Address: Richard C. Eastman, MD, National Institute of Diabetes and Digestive and Kidney Diseases, Bldg 31 Rm 9A16, 31 Center Dr MSC 2560, National Institutes of Health, Bethesda, MD 20892-2560

Issue
Cleveland Clinic Journal of Medicine - 64(8)
Publications
Page Number
410-413
Sections
Author and Disclosure Information

Richard C. Eastman, MD
Director, Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Disease

Address: Richard C. Eastman, MD, National Institute of Diabetes and Digestive and Kidney Diseases, Bldg 31 Rm 9A16, 31 Center Dr MSC 2560, National Institutes of Health, Bethesda, MD 20892-2560

Author and Disclosure Information

Richard C. Eastman, MD
Director, Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Disease

Address: Richard C. Eastman, MD, National Institute of Diabetes and Digestive and Kidney Diseases, Bldg 31 Rm 9A16, 31 Center Dr MSC 2560, National Institutes of Health, Bethesda, MD 20892-2560

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 64(8)
Issue
Cleveland Clinic Journal of Medicine - 64(8)
Page Number
410-413
Page Number
410-413
Publications
Publications
Article Type
Display Headline
Is intensive glycemic control worth the expense?
Display Headline
Is intensive glycemic control worth the expense?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media